Aldebaran Capital »

Onkure Therapeutics Inc-a shares owned by Aldebaran Capital

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Aldebaran Capital from 13F filings

Historical chart of Aldebaran Capital investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Aldebaran Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Aldebaran Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $121k 44k 2.75
2025-06-30 $106k 44k 2.39
2025-03-31 $194k 45k 4.30
2024-12-31 $392k 46k 8.60

More positions owned by Aldebaran Capital

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Occidental Petroleum Corporation (OXY)
Bunge (BG)
Eli Lilly & Co. (LLY)
Bank of America Corporation (BAC)
Ishares Tr Rus Mdcp Val Etf (IWS)
Suncor Energy (SU)
Cato Corp Cl A (CATO)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Verizon Communications (VZ)
Amylyx Pharmaceuticals (AMLX)
Sirius Xm Holdings Common Stock (SIRI)

View all positions for Aldebaran Capital

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a